Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CORIPREV-LR: Lopinavir/Ritonavir for COVID-19 Prevention
NCT04321174Phase 3Unknown
- Sponsor
- Unity Health Toronto
- Start
- Apr 2020
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lopinavir + ritonavir in coronavirus disease 2019 (COVID-19), sponsored by Unity Health Toronto. Status: unknown.
02
Drugs
lopinavir + ritonavir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04321174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04321174.